BIO Announces Therapeutic Workshops for 10th Annual BIO Investor Forum

  • Contact: Abigail Hirsch
  • Phone: 202-962-9235
  • Email: ahirsch@bio.org
  • Recommend
  • Tweet
  • Print
  • Email

WASHINGTON, DC – (September 19, 2011) – The Biotechnology Industry Organization (BIO) today announced the preliminary set of speakers who will be featured on the Therapeutic Workshops during the10thannual BIO Investor Forumto be held October 25 - 26 in San Francisco, CA. 

“The BIO Investor Forum continues to provide unique features not found at other investment events.  This year’s Therapeutic Workshops will once again engage key opinion leaders, clinical specialists, and leading companies to have provocative discussions around the most novel and cutting-edge therapies in the biotech industry, providing a glimpse to investors as to what will drive the market,” said Alan Eisenberg, Executive Vice President of Emerging Companies and Business Development at BIO.

Therapeutic Workshops will feature senior-level industry executives, scientific officers leading clinical experts and patient advocacy groups that represent innovation in the biotech industry.

Therapeutic Workshops include:

  • Immunotherapy: Heal Thyself

The field of immunotherapeutics has piqued the interest of investors as well as pharma companies that will pay top dollar to develop these drugs. Hear experts from companies at the forefront of this exciting field discuss what lies ahead.  

Tuesday, October 25th, 10:30am

Panelists:  Hervé Brailly, PhD, Chief Executive Officer, Innate Pharma SA; Kevin Heller, Director, Immuno-Oncology- Strategic Transactions Group, Bristol-Myers Squibb and Timothy C. Rodell, MD, Chief Executive Officer & President, GlobeImmune, Inc.

  • Antibody Drug-Conjugates: Beyond the ABCs of ADCs

Experts in this specialized antibody field will convene to discuss the latest developments and lessons of bringing Antibody Drug Conjugates (ADC) through the clinic as well as answer the many questions surrounding this hot topic.

Tuesday, October 25th, 1:30pm

Panelists:  Jonathan Drachman, M.D., Senior Vice President, Research and Translational Medicine, Seattle Genetics, Inc. and Timothy B. Lowinger, PhD, Chief Scientific Officer, Mersana Therapeutics, Inc.

  • Diagnostics: X Marks the Spot – Companion Dx in Oncology

Insights into the molecular and genetic basis of disease are driving new product and therapeutic opportunities while changing the treatment paradigm for many cancers. Focusing on these new markets, industry executives and investors will guide a discussion of some of the most compelling new technologies and applications for companion diagnostics in oncology.  

Wednesday, October 26th, 10:30am

Panelist:  Rollie Carlson, PhD, President, Asuragen, Inc.;FasterCures

  • Infectious Disease: Resistance is Futile – SuperDrugs for SuperBugs

While new superbugs are on the rise, new superdrugs to combat these remain few and far between. Hear from leaders at companies riding the next wave of antibiotic drug discovery discuss the opportunities and challenges of this ever-evolving field.

Wednesday, October 26th, 1:30pm

Panelists:  David P. Perry, Chief Executive Officer,  Anacor Pharmaceuticals, Inc.; Jeffrey Stein, PhD, President & CEO, Trius Therapeutics, Inc. and Brian R. Dixon, PhD, President & CEO, BioRelix, Inc.

The 10th annual BIO Investor Forum, celebrating a “Decade of Excellence,” will assemble a select group of public and venture-stage growth companies, as well as top public and private equity investors, to explore investment trends and opportunities in life sciences. In addition to expert-led workshops and panel discussions focusing on industry trends, the conference features presentations by over 100 biotech companies poised to join the growth “watch list” in 2011, as well as a number of nonprofit and venture philanthropy organizations.

To learn more about the BIO Investor Forum, registration and up-to-date workshop program information, please visithere.  Advance media registration is now available here. Registration is complimentary for credentialed members of the media. 

BIO is pleased to recognize the leadership provided by the BIO Investor Forum Conference sponsors.  The sponsors include: Supporting Bank Sponsors, BMO Capital Market; Rodman & Renshaw, LLC and Roth Capital Partners. 

Upcoming BIO Events

BIO India International Partnering Conference
September 21-22, 2011
Hyderabad, India
 
BIO China International Conference
October 12-13, 2011
Shanghai, China
 
10th Annual BIO Investor Forum
October 25-26, 2011
San Francisco, Calif.
 
BIO-Europe 2011
October 31-November 2, 2011
Duesseldorf, Germany

BIO IP Counsels Committee Fall Conference & Meeting

November 2-4, 2011
New York, NY
 

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.